Stable Istotope Labelled Emibetuzumab Biosimilar – Anti-MET/RCCP2 mAb – Research Grade

Reference: PX-TA1351-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Istotope Labelled Emibetuzumab Biosimilar - Anti-MET/RCCP2 mAb - Research Grade
SourceCAS 1365287-97-3
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsLA480,LY-2875358
ReferencePX-TA1351-SIL
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

General information on Anti-MET/RCCP2[Homo sapiens] (Emibetuzumab) Monoclonal Antibody

Emibetuzumab has been investigated in the treatment of Advanced Cancer, Renal Cell Carcinoma, Hepatocellular Cancer, Gastric Adenocarcinoma, and Non-Small Cell Lung Cancer.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Istotope Labelled Emibetuzumab Biosimilar – Anti-MET/RCCP2 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below